Legacy IPC
Venous Thromboembolism (VTE) is recognized as the most preventable cause of death with as many as 70% of cases being prevented. One of the leading contributable factors is the poor compliance and understanding amongst both patients and clinical staff in the use of current Intermittent Pneumatic Compression (IPC) devices. Prevention of VTE can lead to significant cost savings but also improved patient outcomes both within the hospital and in community care.
Legacy IPC (www.legacy-ipc.com) has been developed using a novel patented technology which mimics ambulation and therefore prevents venous stasis, but is silent, compact, portable and lightweight compared to other IPC systems. This improves patient compliance and reduces clinical downtime both within the hospital but also in community care. The Bluetooth communication allows for the devices to be monitored for compliance and control but can also help with rehabilitation regimes following surgery. FDA released for the prevention of DVT, venous ulcers, cutaneous ulcers and reducing edema and compartmental pressure both at home or hospitals.
Please take a look at www.legacy-ipc.com to see the benefits and savings which Legacy IPC can bring to your VTE care prevention.